Latest Stock Split Details
Key information about Titan Pharmaceuticals, Inc.'s most recent stock split
Split Date: 2024-01-09
Split Ratio: 1:20
Price Before Split: $0.36
Price After Split: $0.02
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Titan Pharmaceuticals, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-01-09 | 1:20 | Yes | $0.36 | $0.02 |
| 2020-12-01 | 1:30 | Yes | $0.13 | $0.00 |
| 2019-01-25 | 1:6 | Yes | $0.24 | $0.04 |
| 2015-09-29 | 181:1000 | Yes | $0.73 | $0.13 |
About Titan Pharmaceuticals, Inc.
Company overview and industry information
Titan Pharmaceuticals, Inc. (TTNP) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Titan Pharmaceuticals, Inc. Summary